BANCA MEDIOLANUM S.P.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.18 EUR | -0.29% |
|
+1.50% | +19.29% |
| Apr. 30 | Europeans down after inflation and Eurozone GDP. | AN |
| Apr. 24 | Mib cautiously active; STM uptrend continues. | AN |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- With a P/E ratio at 9.77 for the current year and 9.01 for next year, earnings multiples are highly attractive compared with competitors.
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- Historically, the company has been releasing figures that are above expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Banks
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +19.29% | 8.13B | A- | ||
| +12.00% | 547B | C+ | ||
| +10.60% | 291B | C+ | ||
| +12.04% | 250B | C+ | ||
| +21.78% | 210B | C | ||
| +17.11% | 171B | B- | ||
| +11.40% | 169B | B- | ||
| +11.01% | 164B | C+ | ||
| +3.27% | 143B | B- | ||
| -11.10% | 139B | B- |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- BMED Stock
- Ratings Banca Mediolanum S.p.A.
